Large Portfolio of SARS-CoV-2 Antibody ELISAs from DiaPharma
Posted: November 24, 2020
The quality you trust from DiaPharma
Full portfolio of SARS-CoV-2 Antibody ELISAs to suit your needs for stage of immune response, sensitivity needs, and price point
- Ideal for COVID-19 research, epidemiological studies, vaccine development, long-term efficacy or sustainability of immune response
- Open-system, standard ELISAs that require no special readers and can be automated for higher throughput
New! QUANTITATIVE SARS-CoV-2 ELISAs for detection of IgG antibodies
TECHNOZYM anti SARS-CoV-2 NP IgG ELISA kit
- Reacts sensitively in the early stages of the immune response
- Includes 96 test wells + calibrator and control material
- Cut- off: 5 U/mL
- Negative Agreement: 99.8%
- Positive Agreement (days post symptom onset):
- <5 d: 14.7 %
- 5-10 d: 45.7 %
- 11-15 d: 76.5 %
- > 15 d: 100%
TECHNOZYM anti SARS-CoV-2 RBD IgG test kit
- Reacts sensitively in the later stages of the immune response
- Includes 96 test wells + calibrator and control material
- Cut- off: 5 U/mL
- Negative Agreement: 99.3%
- Positive Agreement (days post symptom onset):
- <5 d: 5.9 %
- 5-10 d: 34.3 %
- 11-15 64.7 %
- >15 d: 100%
Brought to you by our partner, Technoclone. Kits manufactured in Austria in collaboration with Florian Krammer, PhD (Icahn School of Medicine at Mount Sinai, New York)
Research Use Only in the U.S. and Canada. Not for diagnostic procedures.
Also available:
- SARS-CoV-2 ELISAs for detection of IgG or IgA antibodies
- Nucleocapsid-based (N-Protein) target – tested at ~100% specificity
- With this broad range of options, increase sensitivity and improve your serologic testing power at both early and late stages
See our full line of SARS-CoV-2 antibody tests at diapharma.com!
It’s Not Just Support. It’s Solutions.
Over 20 years of scientific expertise, with support just a call or click away.
1.800.447.3846 | techsupport@diapharma.com
Diapharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
ML-00-00735Rev01